logo
Same-day mental health help pledge as demand rises

Same-day mental health help pledge as demand rises

Yahoo29-04-2025
Same-day mental health support without the need for a referral is the aim of a new strategy after calls to an urgent hotline doubled in a year.
A free NHS urgent mental health support phone line which launched in late 2022 gets an average of 6,000 calls each month, while the overall number of calls almost doubled between 2023 and 2024.
The Welsh government's 10-year plan will focus on early intervention without delay and more social prescribing which connects people to community based activities.
Minister for Health and Wellbeing Sarah Murphy said the Welsh government was working to address factors that affect wellbeing.
Analysis from health think-tank the Bevan Commission found the number of people with mental health issues could increase by a third over the next 20 years.
Long waiting times to access specialist support, especially for children and young people were highlighted during a recent consultation, which also found that those from certain economic or ethnic minority backgrounds were disadvantaged.
Simon Jones, head of policy at Mind Cymru, said: "Whilst the direction of travel is what we wanted to see, there must now be clear and consistent leadership to deliver on these commitments with urgency and long-term funding."
Mental health 111 hotline launched in Wales
Mental health service cut a huge risk - charity
Better mental health support needed, charity says
Under the plan, support would be given over the phone, at a GP surgery or local mental health service, who would then find appropriate help.
That could involve social prescribing, where suitable activities in the community are recommended to avoid crises and preventative care.
Sian McEvoy, 41, spends a few days a week volunteering at a community farm near her home in Swansea, which provides opportunities for adults and young people who face mental health challenges.
The experience of being outdoors and working with animals has already started to improve her social anxiety which prevented her from finding employment.
She said: "I got myself into a bit of trouble drinking.
"I came out of detox in February and I wanted to get myself back into the community again because my anxiety around people isn't great, so I thought coming here with the animals would be good for me.
"When I was drinking I didn't leave the house for three years so being out in the community around other people would tear me apart.
"I decided to come here to improve my mental health and get my confidence up to go back working full-time."
The farm's operations manager, Katharine Aylett, said: "Most people self-refer but some come here through their occupational therapist, or a social prescriber in a GP surgery and we have local area co-ordinators who refer people.
"We've seen a huge differences in people. So many tell us about how it's changed their relationships with their families."
Ms Aylett noted there were still challenges within the sector due to the lack of long-term funding for projects that can support wellbeing.
Since becoming a volunteer at the farm, Steffan Thomas, 24, said the experience had made a "huge impact on my mental health".
He said: "If I miss a week I feel a bit sad because I want to be here as much as I can.
"If I need five minutes to myself I like to spend time with just the animals but I tend to like getting stuck in and helping others with their mental health."
Since it launched at the end of 2022, the NHS Wales 111 "press two" mental health urgent support line has recorded an average of 5,969 calls each month.
Prof Kamila Hawthorne who is a GP in Mountain Ash, Rhondda Cynon Taf, and a Bevan Commission commissioner, said: "We know that chronic ill health is rising, both mental and physical.
"If we don't do something to prevent the onwards rise of prevalence then the NHS is going to be overwhelmed.
"It's much better to prevent these things in the first place, enable people to grow up leading healthier lifestyles, having healthier approaches to what they want out of life and how they want to lead their day to day activities."
She added: "I don't think people have really appreciated the power of social prescribing and how good it is to be able to help yourself and have the tools to prevent relapses later on."
Murphy said: "When you go in and ask for help, you'll see somebody almost immediately to have that conversation and not be put on a waiting list for counselling. We're already seeing this in pockets and we need to build on that.
"You want always have perfect physical health or perfect mental health but we're reducing that stigma and ensuring we have more compassionate and person-centred care exactly when people need it."
She added: "We know that good mental health depends on much more than healthcare alone.
"That's why we're working to address all the factors that affect wellbeing, from housing and employment to tackling loneliness and building stronger communities."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Physitrack Announces Commercial Partnership with Leading UK Rehabilitation Provider Pure Physiotherapy
Physitrack Announces Commercial Partnership with Leading UK Rehabilitation Provider Pure Physiotherapy

Yahoo

time20 minutes ago

  • Yahoo

Physitrack Announces Commercial Partnership with Leading UK Rehabilitation Provider Pure Physiotherapy

LONDON, UK / / July 31, 2025 / Physitrack PLC (STO:PTRK) has entered into a commercial partnership with Pure Physiotherapy, one of the UK's leading providers of musculoskeletal (MSK) services, recognised for its nationwide clinical network and large-scale delivery of both NHS and private sector physiotherapy. Pure Physiotherapy delivers evidence-based, outcome-driven MSK care to a diverse population - from private patients seeking specialist physiotherapy to tens of thousands of NHS patients through its extensive First Contact Practitioner (FCP) services. With a rapidly expanding footprint and a reputation for clinical excellence, Pure is a key player in modernising access to physiotherapy across the UK. Under the new agreement, Pure will implement Physitrack's digital health platform across its national clinic network, enabling tailored exercise prescription, remote patient monitoring, and improved clinical engagement. The collaboration aligns with Pure's focus on leveraging technology to deliver scalable, high-quality care that meets both NHS and private sector standards. "We are delighted to be bolstering our relationship with Physitrack, knowing what a valuable tool this is for patients and clinicians alike and look forward to further technological developments in terms of data and tracking to really evidence what a fantastic service we provide. We are excited about further insights into our own service, as well as contributing to the wider data picture around the benefits of Physiotherapy to the population of the UK, both within the NHS and private sector and can see Physitrack as one of the services which helps us fulfil that ambition," said Alison Day, Director of Clinics, Pure Physiotherapy. Henrik Molin, CEO of Physitrack, commented: "Pure Physiotherapy is a standout provider in the UK MSK landscape - combining strong NHS partnerships with a growing private care offering. We're proud to support their commitment to delivering effective, digitally enabled care across communities and clinical settings. The subscription agreement, valued initially at £14,000 per annum and expected to scale significantly with further clinic adoption, marks a strategic advance in Physitrack's UK growth - particularly among leading MSK providers operating at the interface of public and private healthcare. A Spotlight newsroom interview with CEO Henrik Molin on the subject is available here: Enquiries regarding this announcement should be addressed to: Henrik Molin, CEO and co-founder, Physitrack.+44 208 133 9325ir@ About Physitrack Physitrack PLC, founded in 2012, is a global digital healthcare provider, focused on the B2B wellness and virtual-first care markets. With staff with 12 nationalities on four continents, customers in 17 time zones, and end users in 187 countries, Physitrack is a truly global company. The company has two business lines:1. Lifecare - SaaS platform tailored mainly to physiotherapy and musculoskeletal care, enabling practitioners to deliver clinical home exercises, education prescription, outcomes tracking, triaging and Telehealth.2. Wellness / Champion Health - SaaS platform for Employee Wellness and care powered by a combination of world-leading technology and wellness professionals based in the United Kingdom, Germany and the Nordics. Physitrack PLC is headquartered in London, United Kingdom, and listed on Nasdaq First North Premier Growth Market (PTRK). Visit us athttps:// (investor relations) (product marketing) About Champion Health Champion Health, a subsidiary of Physitrack Plc, is a leader in corporate wellness technology, providing an innovative platform that empowers businesses to support their employees' well-being through personalised wellness action plans and advanced analytics. Visit us athttps:// Attachments Physitrack Announces Commercial Partnership with Leading UK Rehabilitation Provider Pure Physiotherapy SOURCE: Physitrack PLC View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Two life-saving medications that no one is using
Two life-saving medications that no one is using

Yahoo

time2 hours ago

  • Yahoo

Two life-saving medications that no one is using

In 2021, varenicline, the most effective single drug for quitting smoking, was withdrawn from the market in the UK because impurities were found at greater levels than is considered safe. Rapidly, varenicline (then sold under its brand names, Champix and Chantix) became unavailable. This was a disaster for public health. Research from University College London estimated that varenicline being unavailable resulted in about 1,890 more avoidable deaths each year because fewer people were successfully quitting smoking. But there was hope. Cytisine (also known as cytisinicline), a naturally occurring plant-based product that had been used for decades in Eastern Europe, and more recently to great effect elsewhere in the world, was licensed in the UK and made available from January 2024. Even so, there was an extended period when neither were available to people trying to quit smoking in the UK (and in other countries, too). But in the UK at least, things were looking up. Based on a limited but growing body of evidence, cytisine probably works as well as varenicline at helping people quit smoking, and it may be better tolerated with fewer side effects. It may also appeal to more smokers who may want to use a natural product rather than a drug designed in a lab. So, with varenicline withdrawn and a similarly effective treatment available, we should have seen lives saved as people who would have taken varenicline were encouraged to try cytisine instead. Why isn't anyone prescribing it? This didn't happen. Cytisine – despite now being licensed and available in the UK – is still shockingly underused. Since January 2024, only 0.2% of people trying to quit smoking have used it (the same proportion that used it in 2018, when it wasn't even officially available in the UK). Official NHS data from people accessing stop-smoking services in England confirm that only 0.7% were prescribed cytisine in 2024. So why is this? High-profile trials continue to show cytisine's effectiveness for quitting smoking (and even for quitting vaping). Maybe cytisine's relatively complex dosing schedule puts people off. Cytisine starts with six pills a day (one every two hours) and gradually tapers off over a few weeks: more confusing and less convenient than one-a-day varenicline. Another possibility is that the public's attention has shifted. With so much focus in recent years on vaping as a smoking cessation aid, prescription drugs for smoking cessation may have fallen off the radar. It could also be that GPs are reluctant to prescribe cytisine because of its cost and the assumption that local authorities should pay for it, not primary care. While it was once hoped that due to its low-cost availability in Eastern Europe, it would become the 'aspirin of smoking cessation drugs', the licensed product in the UK is now as or more expensive than other drugs. But the simplest explanation is probably the most accurate: not enough people know about cytisine. People who smoke, GPs, pharmacists and even stop-smoking services may not know it's an option. And if no one is talking about it, no one is prescribing it. And even if they do know about it, there may be a lack of confidence in using or prescribing it because it is a new drug. That's a problem. The UK government has made the shift from treating illness to preventing it a central part of its health strategy. Smoking remains the leading cause of preventable death in the country and the world. If we're serious about prevention, then effective smoking cessation support must be top of the agenda. Now, varenicline is available again (without its brand names and reformulated to remove the impurities). This is welcome news, but only 1.1% of past-year smokers reported using varenicline. That's only a quarter of the number from before its withdrawal. This raises an important question: should we return to prescribing varenicline by default, or is it time to consider cytisine as a first-line treatment? Researchers are continuing to learn more about cytisine, but as the evidence in favour of cytisine grows, maybe it needs a PR campaign for both prescribers and people who smoke. None of this is to say that cytisine is a miracle cure, or that it will work for everyone. But that's true of every way to help people quit smoking. Quitting smoking is hard, and people trying to quit need more options, not fewer, and those options need to be visible and accessible. Jonathan Livingstone-Banks is a Lecturer & Senior Researcher in Evidence-Based Healthcare at the University of Oxford. Dimitra Kale is a Senior Research Fellow in Health Psychology at UCL. Lion Shahab is a Professor in Health Psychology at UCL. This article is republished from The Conversation under a Creative Commons license. Read the original article.

Now nurses and GPs threaten to strike as NHS braces for winter chaos
Now nurses and GPs threaten to strike as NHS braces for winter chaos

Yahoo

time4 hours ago

  • Yahoo

Now nurses and GPs threaten to strike as NHS braces for winter chaos

NHS patients face months of winter strikes as nurses and GPs are the latest to threaten walkouts if their demands are not met. The Royal College of Nursing (RCN) has warned its members feel 'deeply undervalued' and will be balloted on industrial action if the government fails to increase its current pay offer of 3.6 per cent. It comes as GPs have also threatened to strike, warning minister Stephen Kinnock that the government must action its list of demands to 'avoid a future dispute'. GPs, represented by the British Medical Association, are also set to hold a meeting in September where they will decide on holding further ballots over strike action. Last year, GPs took part in 'collective action' over contract funding. The fresh threats come after a five-day walkout by resident doctors ended on Wednesday, with thousands of staff walking out over the government's refusal to meet their demands for a 29 per cent pay rise. The Department of Health and Social Care (DHSC) said the government 'hugely' values the work of nurses, but stressed the profession has had 'two above-inflation pay rises'. On Wednesday, Health Secretary Wes Streeting issued a warning to leaders at the British Medical Association (BMA), saying he is willing to resume talks in their ongoing dispute over pay and working conditions. But he warned: 'It should be clear to the BMA by now that it will lose a war with this government. It's not too late for us both to win the peace.' Professor Nicola Ranger, general secretary and chief executive of the RCN, said nurses feel 'deeply undervalued'. According to the union, 91 per cent of members voted to reject the pay award on a 56 per cent turnout, with more than 170,000 staff taking part. It warned that the profession faces widespread vacancies, stunted career progression and years of pay erosion, and urged ministers to use the summer to agree an investment plan or face a ballot on industrial action. Meanwhile, Unison, which represents other healthcare workers such as ambulance staff and porters, is consulting members on possible action in response to the 3.6 per cent pay award. On Wednesday, The Independent reported that vital cancer operations were cancelled due to the resident doctors' strikes. But the full scale of the walkouts is yet to be revealed, with NHS England due to publish data on how many operations and appointments were shelved this week. However, it is expected that fewer patients were affected compared to previous strikes after hospitals were ordered to press ahead with as much pre-planned care as possible. In previous walkouts, the majority of non-urgent care was postponed. The latest threat of action from nurses comes after they led the way on strike action over pay in 2022 and 2023, that quickly saw other public sectors, such as train drivers and teachers follow. Announcing the results of the RCN's consultation, Professor Ranger said: 'My profession feels deeply undervalued and that is why record numbers are telling the government to wake up, sense the urgency here and do what's right by them and by patients. 'Record numbers have delivered this verdict on a broken system that holds back nursing pay and careers and hampers the NHS. As a safety-critical profession, keeping hold of experienced nursing staff is fundamentally a safety issue and key to the government's own vision for the NHS. 'Long-overdue reforms to nursing career progression and the NHS pay structure aren't just about fairness and equity but are critical for patient safety.' Following the doctors' strike on pay, the BMA is now in dispute with the government over the number of resident doctors who are unable to get speciality training jobs. It claims that around 30,000 resident doctors have to compete for 10,000 specialist posts each year. A DHSC spokesperson added in response to the RCN: 'This government is clear we can't move any further on headline pay but will work with the RCN to improve their major concerns, including pay structure reform, concerns on career progression and wider working conditions.' ☕ Need to wake up your brain?

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store